4//SEC Filing
Beausang Ellen 4
Accession 0001641172-25-013801
CIK 0000926617other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:05 PM ET
Size
7.8 KB
Accession
0001641172-25-013801
Insider Transaction Report
Form 4
Beausang Ellen
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-06-04−4,843→ 0 total→ Common Stock (4,843 underlying) - Exercise/Conversion
Common Stock
2025-06-04+4,843→ 6,458 total
Footnotes (3)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On March 11, 2025, the reporting person was granted 6,458 RSUs, 4,843 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 1, 2025.
- [F2]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock
- [F3]On March 11, 2025, the reporting person was granted 6,458 RSUs, 4,843 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.
Documents
Issuer
Aspira Women's Health Inc.
CIK 0000926617
Entity typeother
Related Parties
1- filerCIK 0002061533
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:05 PM ET
- Size
- 7.8 KB